Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Has the Proportion of Combat-Related Amputations That Develop Heterotopic Ossification Increased?

Daniels CM, Pavey GJ, Arthur J, Noller M, Forsberg JA, Potter BK.

J Orthop Trauma. 2018 Jun;32(6):283-287. doi: 10.1097/BOT.0000000000001158.

PMID:
29533305
2.

Heterotopic ossification and lessons learned from fifteen years at war: A review of therapy, novel research, and future directions for military and civilian orthopaedic trauma.

Hoyt BW, Pavey GJ, Potter BK, Forsberg JA.

Bone. 2018 Apr;109:3-11. doi: 10.1016/j.bone.2018.02.009. Epub 2018 Feb 17. Review.

PMID:
29462673
3.

Early local delivery of vancomycin suppresses ectopic bone formation in a rat model of trauma-induced heterotopic ossification.

Seavey JG, Wheatley BM, Pavey GJ, Tomasino AM, Hanson MA, Sanders EM, Dey D, Moss KL, Potter BK, Forsberg JA, Qureshi AT, Davis TA.

J Orthop Res. 2017 Nov;35(11):2397-2406. doi: 10.1002/jor.23544. Epub 2017 Apr 11.

PMID:
28390182
4.

Coherency Maximizing Exploration in the Supermarket.

Riefer PS, Prior R, Blair N, Pavey G, Love BC.

Nat Hum Behav. 2017 Jan 9;1. pii: 0017. doi: 10.1038/s41562-016-0017. No abstract available.

5.

Military personnel sustaining Lisfranc injuries have high rates of disability separation.

Balazs GC, Hanley MG, Pavey GJ, Rue JP.

J R Army Med Corps. 2017 Jun;163(3):215-219. doi: 10.1136/jramc-2016-000681. Epub 2016 Dec 9.

PMID:
27940985
6.

Muscarinic receptor binding changes in postmortem Parkinson's disease.

McOmish C, Pavey G, McLean C, Horne M, Dean B, Scarr E.

J Neural Transm (Vienna). 2017 Feb;124(2):227-236. doi: 10.1007/s00702-016-1629-z. Epub 2016 Nov 21.

PMID:
27873015
7.

Targeted stimulation of retinoic acid receptor-γ mitigates the formation of heterotopic ossification in an established blast-related traumatic injury model.

Pavey GJ, Qureshi AT, Tomasino AM, Honnold CL, Bishop DK, Agarwal S, Loder S, Levi B, Pacifici M, Iwamoto M, Potter BK, Davis TA, Forsberg JA.

Bone. 2016 Sep;90:159-67. doi: 10.1016/j.bone.2016.06.014. Epub 2016 Jun 28.

8.

Lower [3H]LY341495 binding to mGlu2/3 receptors in the anterior cingulate of subjects with major depressive disorder but not bipolar disorder or schizophrenia.

McOmish CE, Pavey G, Gibbons A, Hopper S, Udawela M, Scarr E, Dean B.

J Affect Disord. 2016 Jan 15;190:241-248. doi: 10.1016/j.jad.2015.10.004. Epub 2015 Oct 23.

PMID:
26521087
9.

An Analysis of Research from Faculty at U.S. Adult Reconstruction Fellowships.

Formby PM, Pavey GJ, Van Blarcum GS, Mack AW, Newman MT.

J Arthroplasty. 2015 Dec;30(12):2376-9. doi: 10.1016/j.arth.2015.05.051. Epub 2015 Jun 3.

PMID:
26129853
10.

What Risk Factors Predict Recurrence of Heterotopic Ossification After Excision in Combat-related Amputations?

Pavey GJ, Polfer EM, Nappo KE, Tintle SM, Forsberg JA, Potter BK.

Clin Orthop Relat Res. 2015 Sep;473(9):2814-24. doi: 10.1007/s11999-015-4266-1.

11.

Bioburden Increases Heterotopic Ossification Formation in an Established Rat Model.

Pavey GJ, Qureshi AT, Hope DN, Pavlicek RL, Potter BK, Forsberg JA, Davis TA.

Clin Orthop Relat Res. 2015 Sep;473(9):2840-7. doi: 10.1007/s11999-015-4272-3.

12.

Early Characterization of Blast-related Heterotopic Ossification in a Rat Model.

Qureshi AT, Crump EK, Pavey GJ, Hope DN, Forsberg JA, Davis TA.

Clin Orthop Relat Res. 2015 Sep;473(9):2831-9. doi: 10.1007/s11999-015-4240-y.

13.

Risk of Anterior Cruciate Ligament Injury in Athletes on Synthetic Playing Surfaces: A Systematic Review.

Balazs GC, Pavey GJ, Brelin AM, Pickett A, Keblish DJ, Rue JP.

Am J Sports Med. 2015 Jul;43(7):1798-804. doi: 10.1177/0363546514545864. Epub 2014 Aug 27. Review.

PMID:
25164575
14.

Mu opioid receptor availability in people with psychiatric disorders who died by suicide: a case control study.

Scarr E, Money TT, Pavey G, Neo J, Dean B.

BMC Psychiatry. 2012 Aug 28;12:126. doi: 10.1186/1471-244X-12-126.

15.

The effect of estrogen on dopamine and serotonin receptor and transporter levels in the brain: an autoradiography study.

Chavez C, Hollaus M, Scarr E, Pavey G, Gogos A, van den Buuse M.

Brain Res. 2010 Mar 19;1321:51-9. doi: 10.1016/j.brainres.2009.12.093. Epub 2010 Jan 14.

PMID:
20079719
16.

Altered M(1) muscarinic acetylcholine receptor (CHRM1)-Galpha(q/11) coupling in a schizophrenia endophenotype.

Salah-Uddin H, Scarr E, Pavey G, Harris K, Hagan JJ, Dean B, Challiss RA, Watson JM.

Neuropsychopharmacology. 2009 Aug;34(9):2156-66. doi: 10.1038/npp.2009.41. Epub 2009 Apr 29.

17.

Using differential solubilization and 2-D gel electrophoresis to visualize increased numbers of proteins in the human cortex and caudate nucleus and putamen.

Dean B, Pavey G, Smith AI.

Proteomics Clin Appl. 2008 Sep;2(9):1281-9. doi: 10.1002/prca.200800037. Epub 2008 Jul 30.

18.

Increased levels of serotonin 2A receptors and serotonin transporter in the CNS of neuregulin 1 hypomorphic/mutant mice.

Dean B, Karl T, Pavey G, Boer S, Duffy L, Scarr E.

Schizophr Res. 2008 Feb;99(1-3):341-9. Epub 2007 Nov 28.

PMID:
18054201
19.

Cortical serotonin7, 1D and 1F receptors: effects of schizophrenia, suicide and antipsychotic drug treatment.

Dean B, Pavey G, Thomas D, Scarr E.

Schizophr Res. 2006 Dec;88(1-3):265-74. Epub 2006 Aug 17.

PMID:
16916599
20.

5-HT2A and muscarinic receptors in schizophrenia: a postmortem study.

Matsumoto I, Inoue Y, Iwazaki T, Pavey G, Dean B.

Neurosci Lett. 2005 May 13;379(3):164-8. Epub 2005 Jan 25.

PMID:
15843056
21.

Hippocampal 5-hydroxytryptamine receptors: abnormalities in postmortem brain from schizophrenic subjects.

Scarr E, Pavey G, Copolov D, Dean B.

Schizophr Res. 2004 Dec 1;71(2-3):383-92.

PMID:
15474910
22.

Expression of truncated presenilin 2 splice variant in Alzheimer's disease, bipolar disorder, and schizophrenia brain cortex.

Smith MJ, Sharples RA, Evin G, McLean CA, Dean B, Pavey G, Fantino E, Cotton RG, Imaizumi K, Masters CL, Cappai R, Culvenor JG.

Brain Res Mol Brain Res. 2004 Aug 23;127(1-2):128-35.

PMID:
15306129
23.

Measurement of dopamine D2-like receptors in postmortem CNS and pituitary: differential regional changes in schizophrenia.

Dean B, Pavey G, Scarr E, Goeringer K, Copolov DL.

Life Sci. 2004 May 7;74(25):3115-31.

PMID:
15081577
24.

Decreased hippocampal NMDA, but not kainate or AMPA receptors in bipolar disorder.

Scarr E, Pavey G, Sundram S, MacKinnon A, Dean B.

Bipolar Disord. 2003 Aug;5(4):257-64.

PMID:
12895203
25.

Studies on serotonergic markers in the human hippocampus: changes in subjects with bipolar disorder.

Dean B, Scarr E, Pavey G, Copolov D.

J Affect Disord. 2003 Jun;75(1):65-9.

PMID:
12781352
26.

Decreased density of [3H]TCP binding following antipsychotic drug withdrawal in rats.

Scarr E, Parkin FM, Pavey G, Dean B.

Life Sci. 2002 Apr 19;70(22):2699-705.

PMID:
12269396
27.
28.
29.

A change in the density of [(3)H]flumazenil, but not [(3)H]muscimol binding, in Brodmann's Area 9 from subjects with bipolar disorder.

Dean B, Pavey G, McLeod M, Opeskin K, Keks N, Copolov D.

J Affect Disord. 2001 Oct;66(2-3):147-58.

PMID:
11578667
30.
31.
32.

Muscarinic1 and 2 receptor mRNA in the human caudate-putamen: no change in m1 mRNA in schizophrenia.

Dean B, Crook JM, Pavey G, Opeskin K, Copolov DL.

Mol Psychiatry. 2000 Mar;5(2):203-7.

PMID:
10822350
33.

The binding of [3H]AF-DX 384 is reduced in the caudate-putamen of subjects with schizophrenia.

Crook JM, Dean B, Pavey G, Copolov D.

Life Sci. 1999;64(19):1761-71.

PMID:
10353630
34.
35.

[3H]raclopride binding to brain tissue from subjects with schizophrenia: methodological aspects.

Dean B, Pavey G, Opeskin K.

Neuropharmacology. 1997 Jun;36(6):779-86.

PMID:
9225305
36.

Changes in protein kinase C and adenylate cyclase in the temporal lobe from subjects with schizophrenia.

Dean B, Opeskin K, Pavey G, Hill C, Keks N.

J Neural Transm (Vienna). 1997;104(11-12):1371-81.

PMID:
9503283
37.

Neither protein kinase C nor adenylate cyclase are altered in the striatum from subjects with schizophrenia.

Opeskin K, Dean B, Pavey G, Hill C, Keks N, Copolov D.

Schizophr Res. 1996 Nov 15;22(2):159-64.

PMID:
8958600
39.

Changes in the serotonin transporter in the hippocampus of subjects with schizophrenia identified using [3H]paroxetine.

Naylor L, Dean B, Opeskin K, Pavey G, Hill C, Keks N, Copolov D.

J Neural Transm (Vienna). 1996;103(6):749-57.

PMID:
8836936
40.

Serotonin2 receptors and the serotonin transporter in the schizophrenic brain.

Dean B, Hayes W, Opeskin K, Naylor L, Pavey G, Hill C, Keks N, Copolov DL.

Behav Brain Res. 1996;73(1-2):169-75.

PMID:
8788497
41.

[3H]paroxetine binding is altered in the hippocampus but not the frontal cortex or caudate nucleus from subjects with schizophrenia.

Dean B, Opeskin K, Pavey G, Naylor L, Hill C, Keks N, Copolov DL.

J Neurochem. 1995 Mar;64(3):1197-202.

PMID:
7861151
42.

Identification of a dopamine-binding protein on the membrane of the human platelet.

Dean B, McAdam AJ, Sundram S, Pavey G, Harrison LC, Copolov DL.

Biochem J. 1992 Oct 1;287 ( Pt 1):45-50.

43.

Amelioration of experimental parkinsonism by intrahypothalamic administration of haloperidol.

Willis GL, Smith GC, Pavey GM, Sandyk R.

Int J Neurosci. 1992 Jul-Aug;65(1-4):187-97.

PMID:
1341681
44.

Further studies on the neurochemical specificity of 6-hydroxydopamine as compared to radiofrequency lesions.

Willis GL, Sleeman M, Pavey GM, Smith GC.

Brain Res. 1987 Feb 10;403(1):15-21.

PMID:
3103863
45.

Limitations of peritoneoscopy. A review.

Jacobs WH, Pavey G, Landers B, Loeb R.

Mo Med. 1968 Jun;65(6):454-8. Review. No abstract available.

PMID:
4231391

Supplemental Content

Support Center